论文信息 - A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T‐cell lymphoma (PTCL): final results from the T‐ cell consortium trial - 字舞流文

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T‐cell lymphoma (PTCL): final results from the T‐ cell consortium trial

R. Advani | Sonali M. Smith | K. Savage | S. Ansell | A. Evens | S. Horwitz | K. Carson | B. Pro | F. Foss | L. Pinter-Brown | M. Lechowicz | F. Loberiza | A. Beaven | A. Shustov | Julie M. Vose